Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Four glucagon-like peptide-1 (GLP-1) receptor agonists have been known to reduce the risk of adverse cardiovascular events in type 2 diabetic patients but the...
Metabolic Health Digest
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide is under development for the treatment of type 2 diabetes. There is...
Dr. Suhas Erande: A case of T2DM uncontrolled on multiple OADs
CASE OVERVIEW A case of uncontrolled diabetes on oral antidiabetic drugs (OADs) was encountered by Dr. Suhas Erande when a 60 years old female...
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccines
Several variants of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) have been reported in India from the start of the pandemic. Pragya D....
Dr. Sonali Patange: A case of a woman with diabetes, obesity, primary infertility and PCOS
CASE OVERVIEW PCOS is associated with hyperandrogenism, ovulatory and metabolic dysfunction, obesity and insulin resistance. A case of 33 year old woman with diabetes...
Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes
Due to cardiac remodeling and kidney complications, atrial fibrillation or flutter (AFF) risk is high in patients with chronic kidney disease (CKD) and type...
